EpiPen's maker has another problem on its hands (MYL)

Members of the Senate Finance Committee have questions about EpiPen-maker Mylan's relationship with Medicaid.
They just sent a letter to Daniel Levinson, the Inspector General of the US Department of Health and Human Services, to inquire about them.
What the senators would like to know is whether or not Mylan manipulated the Medicaid Drug Rebate Program (MDRP) by classifying EpiPen as a generic drug when it is in fact not.
Mylan started an uproar earlier this month when the price of an EpiPen ro